Melony Valleau - 25 Sep 2023 Form 4 Insider Report for MedMen Enterprises, Inc.

Reporting relationship: CAO
Issuer ticker: N/A
Reported as of: 25 Sep 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Oct 2023, 18:04:30 UTC
Source filing: View source filing
Reporting owner signature: /s/ Melony Valleau

Key filing fact

Melony Valleau filed Form 4 for MedMen Enterprises, Inc. on 04 Oct 2023.

Key facts

This page summarizes Melony Valleau's Form 4 filing for MedMen Enterprises, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Oct 2023, 18:04.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMNFF transaction

Class B Subordinate Voting Shares

Award

Transaction value: $0
Shares: +5,102,041
Change %
Price: $0.000000
Shares after: 5,102,041
Date: 25 Sep 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock units ("RSUs") granted pursuant to Issuer's 2018 Equity Incentive Plan. RSUs are Class B Subordinate Voting Share equivalents and represent a contingent right to receive such shares upon vesting. RSUs vest annually in equal installments on September 25, 2024, 2025 and 2026.